/Companies

CellChorus

YC S21

Houston, US · Founded 2020 · 4 employees · 5 known investors

Find your way into CellChorus

Sign up to see every warm intro you have to CellChorus

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the CellChorus team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

CellChorus develops a visual AI platform called TIMING that performs high-throughput dynamic analysis of single cells, measuring cell activation, killing, and movement over time for biopharmaceutical research. The company serves biopharmaceutical companies and therapy developers seeking to understand cellular function and phenotype.

Founders & leadership· Y Combinator alumni (S21)

CellChorus was founded in 2020 by Dan Meyer, Navin Varadarajan, and Laurence Cooper.

DMDan Meyer
Dan MeyerCo-founder · CEOHe previously served as COO and board member at Genospace before its acquisition by HCA Healthcare, and held investment roles at venture capital firms Arboretum Ventures and PJC.vc. He holds a B.A. in mathematics and economics from Middlebury College and an M.B.A. from Tuck School of Business at Dartmouth.
NVNavin Varadarajan
Navin VaradarajanCo-founder · CSO
LCLaurence Cooper
Laurence CooperCo-founder & Board ChairPhysician and tenured professor at University of Texas MD Anderson Cancer Center with expertise in cellular and gene therapies; former CEO of a public life sciences company and chief of pediatric bone marrow transplantation with leadership of multiple clinical trials in immunotherapy development.
RBRebecca Berdeaux
Rebecca BerdeauxChief Scientific Officer

Investors · 5

Funding

SEC filings, press & company announcements
  • Undisclosed amountSmall Business Innovation Research (SBIR) grantJul 2023
    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Images

CellChorus photo

Related companies · 6

MetoficoMetofico builds a no-code platform for analyzing large and complex datasets in life science research, allowing scientists without programming expertise to extract insights from neuroscience, behavioral tracking, and other experimental data. The tool aims to reduce the time researchers spend on data analysis tasks.
ScispotScispot provides automated sample tracking and traceability software for laboratory environments, replacing manual processes and spreadsheets with end-to-end logging and monitoring capabilities. The platform serves laboratories and research facilities seeking to improve sample management and ensure compliance.
Reverie LabsReverie Labs develops cancer treatments designed to cross the blood-brain barrier and treat tumors in the central nervous system.
Lavo Life SciencesLavo Life Sciences offers computational molecular simulations to pharmaceutical companies, helping them optimize drug formulations, reduce experimental costs, and accelerate the path to clinical trials and regulatory approval.
PostEraPostera uses artificial intelligence and computational chemistry to accelerate drug discovery for pharmaceutical companies. The platform combines machine learning, medicinal chemistry, and software engineering to improve the drug development process.
Cell MicrosystemsCell Microsystems develops automated instruments for cellular and molecular workflows used in life science research, including oncology, stem cell biology, and regenerative medicine. Its products support scientists in laboratory research and single-cell isolation and analysis.

Companies working in the same space as CellChorus.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2023$324.3K
National Science FoundationPhase I2023$275K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Legal entities · 1

corporate structure
CellChorus Inc.

In the news

Frequently asked questions

What does CellChorus do?
CellChorus develops a visual AI platform called TIMING that performs high-throughput dynamic analysis of single cells, measuring cell activation, killing, and movement over time for biopharmaceutical research. The company serves biopharmaceutical companies and therapy developers seeking to understand cellular function and phenotype.
Who founded CellChorus?
CellChorus was founded by Dan Meyer, Navin Varadarajan, Laurence Cooper in 2020.
Who are CellChorus's investors?
CellChorus's investors include Breakout Ventures, Houston Angel Network, Texas HALO Fund, Y Combinator, Asymmetry Ventures.
Where is CellChorus headquartered?
CellChorus is headquartered in Houston, US.